Previous 10 | Next 10 |
Momentus MNTS +40% on signing launch service agreements with SpaceX. HTG Molecular Diagnostics (HTGM) +32% expands features of proprietary HTG EdgeSeq technology. ERYTECH Pharma ERYP +19% British Journal of Haematology publishes positive results from Erytech's phase 2...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re diving into the biggest pre-market stock movers for Thursday that investors are going to want to keep track of today. Source: oneinchpunch/Shutterstock.com Pharmaceutical announcements, insider trading,...
TUCSON, Ariz., April 06, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced that it has improved the sample preparation protocol for its ...
TUCSON, Ariz., March 31, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, has released its first proof-of-approach white paper (the “White...
HTG Molecular Diagnostics, Inc. (HTGM) Q4 2021 Earnings Conference Call March 29, 2022 16:30 ET Corporate Participants Andrew Eriksen - IR, LifeSci Advisors John Lubniewski - Chief Executive Officer Shaun McMeans - Chief Financial Officer Conference Call Participants Rick Krause - Cantor Fitz...
HTG Molecular press release (NASDAQ:HTGM): FY GAAP EPS of -$2.47 misses by $0.10. Revenue of $8.91M (+4.2% Y/Y) in-line. Shares +0.63%. For further details see: HTG Molecular GAAP EPS of -$2.47 misses by $0.10, revenue of $8.91M in-line
TUCSON, Ariz., March 29, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported its financial results for the year ended December 3...
AMPE, AREC, CALM, CHWY, CRMD, CWBR, CWCO, HTGM, INFI, OTCQB:LQMT, LULU, MLKN, MOTS, MU, MVST, NBRV, NBY, OTC:OIBZQ, OPGN, PAVM, PRGS, PVH, RH, SNDL, SPWH, SUNL, VRNT, ZVO For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Tuesd...
HTG Molecular (NASDAQ:HTGM) is scheduled to announce FY earnings results on Tuesday, March 29th, after market close. The consensus EPS Estimate is -$2.68 (+40.6% Y/Y) and the consensus Revenue Estimate is $8.91M (+4.2% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revisions a...
TUCSON, Ariz., March 22, 2022 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today announced that it will report its financial results for the year ...
News, Short Squeeze, Breakout and More Instantly...
HTG Molecular Diagnostics Inc. Company Name:
HTGM Stock Symbol:
NASDAQ Market:
HTG Molecular Diagnostics Inc. Website:
TUCSON, Ariz., May 18, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today announced that its management team will present the advantages of its proprietary drug discovery engine at the 2023 Biot...
TUCSON, Ariz., May 16, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported achievement of another technical milestone in its drug discovery business. HTG is pioneering a proprietar...
TUCSON, Ariz., May 10, 2023 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a platform-based life science tools and drug discovery company, today reported financial results for the quarter ended March 31, 2023 and provided recent drug discovery business highlig...